Found: 16
Select item for more details and to access through your institution.
A campaign to improve the mental health of medical students.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Double-Edged Sword of Extremely High Prices for Gene Therapies in Sickle Cell Disease.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
The lucent yet opaque challenge of regulating artificial intelligence in radiology.
- Published in:
- NPJ Digital Medicine, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s41746-024-01071-2
- By:
- Publication type:
- Article
National Comprehensive Cancer Network Guideline Recommendations of Cancer Drugs With Accelerated Approval.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2343285, doi. 10.1001/jamanetworkopen.2023.43285
- By:
- Publication type:
- Article
Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2342195, doi. 10.1001/jamanetworkopen.2023.42195
- By:
- Publication type:
- Article
Dietary interventions in cancer: a systematic review of all randomized controlled trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 7, p. 1026, doi. 10.1093/jnci/djae051
- By:
- Publication type:
- Article
Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015–2020.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00750-1
- By:
- Publication type:
- Article
Frontline polatuzumab vedotin for diffuse large B‐cell lymphoma: A survey of clinician impressions.
- Published in:
- EJHaem, 2022, v. 3, n. 3, p. 930, doi. 10.1002/jha2.505
- By:
- Publication type:
- Article
The promise and harms of screening for plasma cell dyscrasias.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 6, p. 704, doi. 10.1111/bjh.18634
- By:
- Publication type:
- Article
We must grow the Australian Bone Marrow Donor Registry.
- Published in:
- Internal Medicine Journal, 2021, v. 51, n. 11, p. 1771, doi. 10.1111/imj.15570
- By:
- Publication type:
- Article
Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease—Estimating the True Value.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 17, p. 1471, doi. 10.1001/jama.2024.2396
- By:
- Publication type:
- Article
Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A Cost-Effectiveness Analysis.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 12, p. 1625, doi. 10.7326/M22-2276
- By:
- Publication type:
- Article
Characteristics of post hoc subgroup analyses of oncology clinical trials: a systematic review.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 6, p. 1, doi. 10.1093/jncics/pkad100
- By:
- Publication type:
- Article
Trends in Medicare Spending on Oral Drugs for Chronic Lymphocytic Leukemia From 2014 to 2020.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e237467, doi. 10.1001/jamanetworkopen.2023.7467
- By:
- Publication type:
- Article